½Å°æº´Áõ ÅëÁõ Áã ô¼ö°­ ³»·Î Åõ¿©ÇÑ TianeptineÀÇ Ç×ÀÌÁúÅë È¿°ú
Antiallodynic effects of intrathecal tianeptine in a neuropathic pain rat

Anesthesia and Pain Medicine 2014³â 9±Ç 2È£ p.93 ~ p.97

¸²ÇØ(Lin Hai) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶ÃëÅëÁõÀÇÇб³½Ç
ÀÌÇü°ï(Lee Hyung-Gon) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶ÃëÅëÁõÀÇÇб³½Ç
À¯¸íÇÏ(Yoon Myung-Ha) - Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ¸¶ÃëÅëÁõÀÇÇб³½Ç

Abstract

Background:Tianeptine is an antidepressant drug which is used for treating depression. Interestingly, the tianeptine has shown antinociceptive effects within a variety of nociceptions. The aim of this study is to investigate the antiallodynic effects of tianeptine in neuropathic pain rats and also determine the involvements of serotonergic, alpha-2 adrenergic and adenosine receptors at the spinal level.

Methods:Neuropathic pain was induced by ligation of left lumbar at 5th and 6th spinal nerves in male Sprague-Dawley rats. PE-10 catheters were placed into the thoracolumbar subarachnoid space for drug injections. Mechanical allodynia was evaluated by mea-suring the withdrawal threshold to von Frey filament when applying on the plantar surface of rats. The effects of intrathecal tianeptine were observed at 15, 30, 60, 90, 120, 150, 180 minutes after delivery. Antagonists for serotonergic (dihydroergocristine), alpha-2 adrenergic (yohimbine) and adenosine (CGS 15943) receptors were intrathecally administered 10 minutes prior to tianeptine in order to evaluate the involvement of both receptors.

Results:Intrathecal tianeptine increased dose-dependently at the withdrawal threshold in the ligated paw. Pretreatment with intrat-hecal dihydroergocristine, yohimbine and CGS 15943 antagonized the antiallodynic effects of tianeptine.

Conclusions: These results suggested that intrathecal tianeptine attenuates the spinal nerve ligation induced tactile allodynia. Serotonergic, alpha-2 adrenergic and adenosine receptors are all involved in the antiallodynic effects of tianeptine at the spinal level.

Å°¿öµå

Adenosine receptor, Alpha-2 adrenergic receptor, Antiallodynia, Neuropathic pain, Serotonin receptor, Tianeptine
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå